{"id":18651,"date":"2022-01-06T13:03:56","date_gmt":"2022-01-06T10:03:56","guid":{"rendered":"https:\/\/zdmaa.com\/how-cancer-uses-normal-cells-for-its-needs\/"},"modified":"2022-01-07T08:56:03","modified_gmt":"2022-01-07T05:56:03","slug":"how-cancer-uses-normal-cells-for-its-needs","status":"publish","type":"post","link":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/","title":{"rendered":"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r?"},"content":{"rendered":"<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"><span class=\"\" style=\"vertical-align: inherit;\">Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r?<\/span><\/span><\/span><\/span><\/p>\n<div>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Kurnaz kanser h\u00fccreleri, geli\u015fmek ve hayatta kalmak s\u00f6z konusu oldu\u011funda genellikle neyin i\u015fe yaray\u0131p neyin yaramad\u0131\u011f\u0131n\u0131 bilir. <\/span><span class=\"\" style=\"vertical-align: inherit;\">D\u00fczensiz h\u00fccreler b\u00f6l\u00fcnmek, b\u00fcy\u00fcmek ve bazen uzak organlara seyahat etmek i\u00e7in normal h\u00fccresel davran\u0131\u015f kurallar\u0131n\u0131 \u00e7i\u011fnerken, sa\u011fl\u0131kl\u0131 h\u00fccrelerin hain g\u00fcndemlerini ilerletmek i\u00e7in kulland\u0131klar\u0131 baz\u0131 normal i\u015flevleri de benimserler. <\/span><span style=\"vertical-align: inherit;\">Philadelphia&#8217;daki Hastanemizde cerrahi \u015fefi ve jinekolojik onkoloji ve robotik cerrahi direkt\u00f6r\u00fc Justin Chura, &#8220;Bu h\u00fccresel i\u015flevler bizim i\u00e7in iyidir, ancak kanser h\u00fccreleri i\u00e7in de iyidir&#8221; diyor.<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Kanser h\u00fccrelerinde bu davran\u0131\u015f\u0131 durdurmak i\u00e7in doktorlar inhibit\u00f6r denilen ila\u00e7lar\u0131 kullanabilirler. <\/span><span style=\"vertical-align: inherit;\">\u0130simlerine uygun olarak inhibit\u00f6rler, h\u00fccreler i\u00e7indeki belirli eylemleri engellemek i\u00e7in tasarlanm\u0131\u015ft\u0131r ve \u00e7o\u011fu durumda belirli enzimleri hedefler. <\/span><span style=\"vertical-align: inherit;\">Bu enzimlerle oynamak, deri d\u00f6k\u00fcnt\u00fcleri ve sindirim rahats\u0131zl\u0131klar\u0131ndan y\u00fcksek tansiyon ve otoimm\u00fcn hastal\u0131klara kadar y\u00f6netilmesi veya tedavi edilmesi gereken \u00e7ok \u00e7e\u015fitli yan etkilere yol a\u00e7abilir.<\/span><\/span><\/p>\n<h2><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Engelleyici ila\u00e7lar nelerdir?<\/span><\/span><\/h2>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u0130nhibit\u00f6r ila\u00e7lar, \u00e7e\u015fitli hastal\u0131k ve durumlar\u0131 tedavi etmek i\u00e7in kullan\u0131l\u0131r. <\/span><span style=\"vertical-align: inherit;\">Omeprazol (Prelosak <\/span><\/span><sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u00ae<\/span><\/span><\/sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> ), \u00f6rne\u011fin midede asidi serbest b\u0131rakan enzimi \u00f6nleyen bir <\/span><span style=\"vertical-align: inherit;\">proton pompas\u0131 inhibit\u00f6r\u00fc. <\/span><span style=\"vertical-align: inherit;\">Baz\u0131 mide \u00fclserlerini ve asit refl\u00fc hastal\u0131\u011f\u0131n\u0131 tedavi etmek i\u00e7in kullan\u0131l\u0131r. <\/span><span style=\"vertical-align: inherit;\">Son y\u0131llarda, ABD G\u0131da ve \u0130la\u00e7 Dairesi kanserle sava\u015fan yeni inhibit\u00f6r ila\u00e7lar\u0131 onaylad\u0131. <\/span><span style=\"vertical-align: inherit;\">\u0130lk olarak 2010 y\u0131l\u0131nda onaylanan kontrol noktas\u0131 inhibit\u00f6rleri, cilt kanseri ve akci\u011fer kanseri gibi tedavisi zor baz\u0131 kanserlerle m\u00fccadelede umut verici sonu\u00e7lar g\u00f6stermi\u015ftir. <\/span><span style=\"vertical-align: inherit;\">Bu ila\u00e7lar, kanser h\u00fccrelerinin ba\u011f\u0131\u015f\u0131kl\u0131k sisteminden saklanmas\u0131na yard\u0131mc\u0131 olan sinyal resept\u00f6rlerini bloke eder. <\/span><span style=\"vertical-align: inherit;\">\u0130nhibit\u00f6rler ve <\/span><span style=\"vertical-align: inherit;\">yayg\u0131n olan ila\u00e7lar kontrol noktalar\u0131nda Bembroleezzomab (Keytruda olan <\/span><\/span><sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u00ae<\/span><\/span><\/sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> ) ve Nivolumab (Opdivo <\/span><\/span><sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u00ae<\/span><\/span><\/sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> ).<\/span><\/span><\/p>\n<p><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Kanseri tedavi etmek i\u00e7in kullan\u0131labilecek di\u011fer yayg\u0131n inhibit\u00f6r ila\u00e7lara \u00f6rnekler:<\/span><\/span><\/p>\n<p><strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">PARP inhibit\u00f6rleri:<\/span><\/span><\/strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Yumurtal\u0131k kanseri i\u00e7in yeni bir tedavi olan bu ila\u00e7lar, kanser h\u00fccrelerinin DNA&#8217;lar\u0131ndaki hasar\u0131 onarmas\u0131n\u0131 \u00f6nlemek i\u00e7in tasarlanm\u0131\u015ft\u0131r. <\/span><span style=\"vertical-align: inherit;\">Hasar tamir edilmedi\u011finde h\u00fccreler \u00f6lebilir. <\/span><span style=\"vertical-align: inherit;\">H\u00fccreler, DNA&#8217;lar\u0131na zarar verebilecek kimyasallar veya g\u00fcne\u015f \u0131\u015f\u0131\u011f\u0131 gibi d\u0131\u015f g\u00fc\u00e7lerin s\u00fcrekli sald\u0131r\u0131s\u0131 alt\u0131ndad\u0131r. <\/span><span style=\"vertical-align: inherit;\">H\u00fccre b\u00f6l\u00fcnmesi ayr\u0131ca DNA replikasyonunda hatalara neden olabilir. <\/span><span style=\"vertical-align: inherit;\">Normal veya kanserli h\u00fccreler, poli-ADP-riboz polimeraz (PARP) ad\u0131 verilen bir protein ile hasar\u0131 izleyebilir ve hasar\u0131 onarmak i\u00e7in genleri \u00e7a\u011f\u0131rabilir. <\/span><span style=\"vertical-align: inherit;\">PARP inhibit\u00f6rleri, kanser h\u00fccrelerinde onar\u0131m s\u00fcrecini durdurmak ve hasarl\u0131 h\u00fccrelerin \u00f6lmesine izin vermek i\u00e7in tasarlanm\u0131\u015ft\u0131r. <\/span><span style=\"vertical-align: inherit;\">Yumurtal\u0131k kanserini tedavi etmek i\u00e7in kullan\u0131lan yayg\u0131n PARP inhibit\u00f6rleri, Aral\u0131k 2014&#8217;te FDA onay\u0131 alan olaparib (Lynparza\u00ae) ve FDA taraf\u0131ndan 2016&#8217;da onaylanan rucaparib&#8217;dir (Rubraca\u00ae).<\/span><\/span><\/p>\n<p><strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Proteazom inhibit\u00f6rleri:<\/span><\/span><\/strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> Bu ila\u00e7lar, kanser h\u00fccrelerinin eski proteinleri yenilerine d\u00f6n\u00fc\u015ft\u00fcrmesini ve h\u00fccreye zarar verebilecek proteinlerde toksik bir art\u0131\u015fa neden olmas\u0131n\u0131 \u00f6nlemek i\u00e7in tasarlanm\u0131\u015ft\u0131r. <\/span><span style=\"vertical-align: inherit;\">Proteazomlar, h\u00fccreler i\u00e7inde proteinleri par\u00e7alayarak geri d\u00f6n\u00fc\u015ft\u00fcr\u00fclebilmeleri i\u00e7in t\u00fcp benzeri yap\u0131lard\u0131r. <\/span><span style=\"vertical-align: inherit;\">Kanser h\u00fccreleri, di\u011fer h\u00fccrelerden daha fazla proteazomlara g\u00fcvenebilir, \u00e7\u00fcnk\u00fc kontrols\u00fcz b\u00fcy\u00fcmeleri s\u0131kl\u0131kla proteinin a\u015f\u0131r\u0131 \u00fcretimine yol a\u00e7ar. <\/span><span style=\"vertical-align: inherit;\">Proteazom inhibit\u00f6rlerinin ayr\u0131ca, apoptoz ad\u0131 verilen sa\u011fl\u0131kl\u0131 h\u00fccrelerde normal bir s\u00fcre\u00e7 olan h\u00fccre \u00f6l\u00fcm\u00fcn\u00fc destekleyen protein seviyelerini artt\u0131rd\u0131\u011f\u0131 d\u00fc\u015f\u00fcn\u00fclmektedir. <\/span><span style=\"vertical-align: inherit;\">Albrootozum ortak inhibit\u00f6r\u00fc , <\/span><span style=\"vertical-align: inherit;\">multipl miyelomun tedavisi i\u00e7in onaylanm\u0131\u015ft\u0131r, bortezomib&#8217;dir (Vilkad <\/span><\/span><sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">\u00ae<\/span><\/span><\/sup><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> ).<\/span><\/span><\/p>\n<p><strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Anjiyogenez inhibit\u00f6rleri:<\/span><\/span><\/strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> Bu ila\u00e7lar, kanser h\u00fccrelerinin yeni bir kan kayna\u011f\u0131 geli\u015ftirmesini \u00f6nlemek i\u00e7in kullan\u0131labilir. <\/span><span style=\"vertical-align: inherit;\">Anjiyogenez, h\u00fccrelerin yeni kan damarlar\u0131 olu\u015fturma s\u00fcrecidir. <\/span><span style=\"vertical-align: inherit;\">T\u00fcm\u00f6rler belirli bir boyuta ula\u015ft\u0131\u011f\u0131nda, v\u00fccudun damar sistemine ula\u015fmak i\u00e7in b\u00fcy\u00fcme fakt\u00f6r\u00fc resept\u00f6rleri ad\u0131 verilen proteinleri kullan\u0131rlar ve t\u00fcm\u00f6r b\u00fcy\u00fcmesine yard\u0131mc\u0131 olabilecek sabit bir kan ak\u0131\u015f\u0131 olu\u015ftururlar. <\/span><span style=\"vertical-align: inherit;\">Anjiyogenez inhibit\u00f6rleri, b\u00fcy\u00fcme fakt\u00f6r\u00fc proteinlerini arar ve bunlar\u0131n \u00e7al\u0131\u015fmas\u0131n\u0131 engelleyerek t\u00fcm\u00f6r\u00fcn besin kayna\u011f\u0131n\u0131 keser. <\/span><span style=\"vertical-align: inherit;\">Kanseri tedavi etmek i\u00e7in yayg\u0131n olarak kullan\u0131lan anjiyogenez inhibit\u00f6rleri, bir\u00e7ok kanseri tedavi etmek i\u00e7in kullan\u0131labilen bevacizumab (Avastin\u00ae) ve kolorektal kanseri tedavi etmek i\u00e7in kullan\u0131labilen setuksimab&#8217;d\u0131r (Erbitux\u00ae).<\/span><\/span><\/p>\n<p><strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\">Tirozin kinaz inhibit\u00f6rleri:<\/span><\/span><\/strong><span style=\"vertical-align: inherit;\"><span style=\"vertical-align: inherit;\"> Bu blok sinyalleri, h\u00fccrenin b\u00fcy\u00fcmesine veya \u00e7o\u011falmas\u0131na neden olabilecek h\u00fccre \u00e7ekirde\u011fine g\u00f6nderilir. <\/span><span style=\"vertical-align: inherit;\">Tirozin kinazlar kanser h\u00fccrelerinde s\u0131kl\u0131kla a\u015f\u0131r\u0131 aktiftir ve sinyal molek\u00fcl\u00fc taraf\u0131ndan aktive edildi\u011finde kontrols\u00fcz b\u00fcy\u00fcmeye veya h\u00fccre b\u00f6l\u00fcnmesine yol a\u00e7abilirler. <\/span><span style=\"vertical-align: inherit;\">Tirozin kinaz inhibit\u00f6rleri bu enzimleri bloke eder ve t\u00fcm\u00f6r b\u00fcy\u00fcmesini durdurabilir veya yava\u015flatabilir. <\/span><span style=\"vertical-align: inherit;\">Kanseri tedavi etmek i\u00e7in yayg\u0131n olarak kullan\u0131lan tirozin kinaz inhibit\u00f6rleri, l\u00f6semiyi tedavi etmek i\u00e7in kullan\u0131labilen imatinib (Gleevec\u00ae) ve h\u00fccre h\u00fccreli akci\u011fer kanserini tedavi etmek i\u00e7in kullan\u0131labilen krizotinibdir (Xalkori\u00ae).<\/span><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? Kurnaz kanser h\u00fccreleri, geli\u015fmek ve hayatta kalmak s\u00f6z konusu oldu\u011funda genellikle neyin i\u015fe yaray\u0131p neyin yaramad\u0131\u011f\u0131n\u0131 bilir. D\u00fczensiz h\u00fccreler b\u00f6l\u00fcnmek, b\u00fcy\u00fcmek ve bazen uzak organlara seyahat etmek i\u00e7in normal h\u00fccresel davran\u0131\u015f kurallar\u0131n\u0131 \u00e7i\u011fnerken, sa\u011fl\u0131kl\u0131 h\u00fccrelerin hain g\u00fcndemlerini ilerletmek i\u00e7in kulland\u0131klar\u0131 baz\u0131 normal i\u015flevleri de benimserler. Philadelphia&#8217;daki Hastanemizde cerrahi &hellip;<\/p>\n","protected":false},"author":1,"featured_media":17705,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-18651","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-tr"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? - zdmaa<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? - zdmaa\" \/>\n<meta property=\"og:description\" content=\"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? Kurnaz kanser h\u00fccreleri, geli\u015fmek ve hayatta kalmak s\u00f6z konusu oldu\u011funda genellikle neyin i\u015fe yaray\u0131p neyin yaramad\u0131\u011f\u0131n\u0131 bilir. D\u00fczensiz h\u00fccreler b\u00f6l\u00fcnmek, b\u00fcy\u00fcmek ve bazen uzak organlara seyahat etmek i\u00e7in normal h\u00fccresel davran\u0131\u015f kurallar\u0131n\u0131 \u00e7i\u011fnerken, sa\u011fl\u0131kl\u0131 h\u00fccrelerin hain g\u00fcndemlerini ilerletmek i\u00e7in kulland\u0131klar\u0131 baz\u0131 normal i\u015flevleri de benimserler. Philadelphia&#8217;daki Hastanemizde cerrahi &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/\" \/>\n<meta property=\"og:site_name\" content=\"zdmaa\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-06T10:03:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-07T05:56:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/couple-g23cc5f287_640.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"427\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/\",\"url\":\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/\",\"name\":\"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? - zdmaa\",\"isPartOf\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/couple-g23cc5f287_640.jpg\",\"datePublished\":\"2022-01-06T10:03:56+00:00\",\"dateModified\":\"2022-01-07T05:56:03+00:00\",\"author\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\"},\"breadcrumb\":{\"@id\":\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#primaryimage\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/couple-g23cc5f287_640.jpg\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/couple-g23cc5f287_640.jpg\",\"width\":640,\"height\":427,\"caption\":\"How Cancer Uses Normal Cells for Its Needs?\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\/\/zdmaa.com\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#website\",\"url\":\"https:\/\/zdmaa.com\/tr\/ro\/\",\"name\":\"zdmaa\",\"description\":\"zdmaa\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/zdmaa.com\/tr\/ro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1780188557\",\"contentUrl\":\"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1780188557\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/zdmaa.com\"],\"url\":\"https:\/\/zdmaa.com\/tr\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? - zdmaa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/","og_locale":"tr_TR","og_type":"article","og_title":"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? - zdmaa","og_description":"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? Kurnaz kanser h\u00fccreleri, geli\u015fmek ve hayatta kalmak s\u00f6z konusu oldu\u011funda genellikle neyin i\u015fe yaray\u0131p neyin yaramad\u0131\u011f\u0131n\u0131 bilir. D\u00fczensiz h\u00fccreler b\u00f6l\u00fcnmek, b\u00fcy\u00fcmek ve bazen uzak organlara seyahat etmek i\u00e7in normal h\u00fccresel davran\u0131\u015f kurallar\u0131n\u0131 \u00e7i\u011fnerken, sa\u011fl\u0131kl\u0131 h\u00fccrelerin hain g\u00fcndemlerini ilerletmek i\u00e7in kulland\u0131klar\u0131 baz\u0131 normal i\u015flevleri de benimserler. Philadelphia&#8217;daki Hastanemizde cerrahi &hellip;","og_url":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/","og_site_name":"zdmaa","article_published_time":"2022-01-06T10:03:56+00:00","article_modified_time":"2022-01-07T05:56:03+00:00","og_image":[{"width":640,"height":427,"url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/couple-g23cc5f287_640.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"admin","Tahmini okuma s\u00fcresi":"4 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/","url":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/","name":"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r? - zdmaa","isPartOf":{"@id":"https:\/\/zdmaa.com\/tr\/ro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#primaryimage"},"image":{"@id":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#primaryimage"},"thumbnailUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/couple-g23cc5f287_640.jpg","datePublished":"2022-01-06T10:03:56+00:00","dateModified":"2022-01-07T05:56:03+00:00","author":{"@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3"},"breadcrumb":{"@id":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#primaryimage","url":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/couple-g23cc5f287_640.jpg","contentUrl":"https:\/\/zdmaa.com\/wp-content\/uploads\/2022\/01\/couple-g23cc5f287_640.jpg","width":640,"height":427,"caption":"How Cancer Uses Normal Cells for Its Needs?"},{"@type":"BreadcrumbList","@id":"https:\/\/zdmaa.com\/tr\/how-cancer-uses-normal-cells-for-its-needs\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/zdmaa.com\/tr\/"},{"@type":"ListItem","position":2,"name":"Kanser, ihtiya\u00e7lar\u0131 i\u00e7in normal h\u00fccreleri nas\u0131l kullan\u0131r?"}]},{"@type":"WebSite","@id":"https:\/\/zdmaa.com\/tr\/ro\/#website","url":"https:\/\/zdmaa.com\/tr\/ro\/","name":"zdmaa","description":"zdmaa","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zdmaa.com\/tr\/ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/8aad4cf5d562d4ca835487f6149853e3","name":"admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/zdmaa.com\/tr\/ro\/#\/schema\/person\/image\/","url":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1780188557","contentUrl":"https:\/\/zdmaa.com\/wp-content\/litespeed\/avatar\/dff6d89ac221c1aaf9366bf5b4cd32de.jpg?ver=1780188557","caption":"admin"},"sameAs":["https:\/\/zdmaa.com"],"url":"https:\/\/zdmaa.com\/tr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/18651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/comments?post=18651"}],"version-history":[{"count":1,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/18651\/revisions"}],"predecessor-version":[{"id":18669,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/posts\/18651\/revisions\/18669"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/media\/17705"}],"wp:attachment":[{"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/media?parent=18651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/categories?post=18651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zdmaa.com\/tr\/wp-json\/wp\/v2\/tags?post=18651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}